Skip to main content
Premium Trial:

Request an Annual Quote

Seegene Gets CE Mark for GI Infectious Disease Test

NEW YORK (GenomeWeb) – South Korea's Seegene announced on Monday that it has received CE-IVD marking for its Allplex Gastrointestinal Full Panel Assay, a multiplexed real-time PCR test for gastrointestinal infection.

The assay, which is now cleared for marketing in Europe and certain other regions, covers 25 bacterial, viral, and parasitic causes of gastrointestinal infectious disease.

"We are pleased to launch the Allplex GI assay in countries recognizing the CE mark," Seegene CEO Jong-Yoon Chun said in a statement. "As part of Seegene's global expansion initiatives in the molecular diagnostics market, we will continue to pursue a series of future submissions of other Allplex infectious disease tests in Europe, Canada, and the US markets."

Earlier this year, Seegene received Canadian approval for its respiratory disease assay and US approval for its herpes simplex virus 1 and 2 assay.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.